Dr. Vick Tejwani is a pulmonologist and physician-scientist at Cleveland Clinic whose research focuses on Alpha-1, including the complex clinical significance of the Pi*MZ genotype. His work explores lung function, disease severity, biomarkers, genetic modifiers, and emerging approaches to Alpha-1 detection.
At the 2026 CRC Forum, Dr. Tejwani presented “Pi*MZ Alpha-1 Antitrypsin Heterozygosity: What We Know, What We Don’t, and What Comes Next,” examining current evidence, unanswered questions, and future research needed to provide clearer clinical guidance.
